Cargando…
Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model
BACKGROUND: Biological augmentation of rotator cuff repair is of growing interest to improve biomechanical properties and prevent re-tearing. But intraoperative single shot growth factor application appears not sufficient to provide healing support in the physiologic growth factor expression peaks....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417541/ https://www.ncbi.nlm.nih.gov/pubmed/25888096 http://dx.doi.org/10.1186/s12891-015-0542-1 |
_version_ | 1782369374813814784 |
---|---|
author | Buchmann, Stefan Sandmann, Gunther H Walz, Lars Reichel, Thomas Beitzel, Knut Wexel, Gabriele Tian, Weiwei Battmann, Achim Vogt, Stephan Winter, Gerhard Imhoff, Andreas B |
author_facet | Buchmann, Stefan Sandmann, Gunther H Walz, Lars Reichel, Thomas Beitzel, Knut Wexel, Gabriele Tian, Weiwei Battmann, Achim Vogt, Stephan Winter, Gerhard Imhoff, Andreas B |
author_sort | Buchmann, Stefan |
collection | PubMed |
description | BACKGROUND: Biological augmentation of rotator cuff repair is of growing interest to improve biomechanical properties and prevent re-tearing. But intraoperative single shot growth factor application appears not sufficient to provide healing support in the physiologic growth factor expression peaks. The purpose of this study was to establish a sustained release of granulocyte-colony stimulating factor (G-CSF) from injectable vesicular phospholipid gels (VPGs) in vitro and to examine biocompatibility and influence on histology and biomechanical behavior of G-CSF loaded VPGs in a chronic supraspinatus tear rat model. METHODS: G-CSF loaded VPGs were produced by dual asymmetric centrifugation. In vitro the integrity, stability and release rate were analyzed. In vivo supraspinatus tendons of 60 rats were detached and after 3 weeks a transosseous refixation with G-CSF loaded VPGs augmentation (n = 15; control, placebo, 1 and 10 μg G-CSF/d) was performed. 6 weeks postoperatively the healing site was analyzed histologically (n = 9; H&E by modified MOVIN score/Collagen I/III) and biomechanically (n = 6). RESULTS: In vitro testing revealed stable proteins after centrifugation and a continuous G-CSF release of up to 4 weeks. Placebo VPGs showed histologically no negative side effects on the healing process. Histologically in vivo testing demonstrated significant advantages for G-CSF 1 μg/d but not for G-CSF 10 μg/d in Collagen III content (p = 0.035) and a higher Collagen I/III ratio compared to the other groups. Biomechanically G-CSF 1 μg/d revealed a significant higher load to failure ratio (p = 0.020) compared to control but no significant differences in stiffness. CONCLUSIONS: By use of VPGs a continuous growth factor release could be obtained in vitro. The in vivo results demonstrate an improvement of immunohistology and biomechanical properties with a low dose G-CSF application via VPG. The VPG itself was well tolerated and had no negative influence on the healing behavior. Due to the favorable properties (highly adhesive, injectable, biocompatible) VPGs are a very interesting option for biologic augmentation. The study may serve as basis for further research in growth factor application models. |
format | Online Article Text |
id | pubmed-4417541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44175412015-05-04 Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model Buchmann, Stefan Sandmann, Gunther H Walz, Lars Reichel, Thomas Beitzel, Knut Wexel, Gabriele Tian, Weiwei Battmann, Achim Vogt, Stephan Winter, Gerhard Imhoff, Andreas B BMC Musculoskelet Disord Research Article BACKGROUND: Biological augmentation of rotator cuff repair is of growing interest to improve biomechanical properties and prevent re-tearing. But intraoperative single shot growth factor application appears not sufficient to provide healing support in the physiologic growth factor expression peaks. The purpose of this study was to establish a sustained release of granulocyte-colony stimulating factor (G-CSF) from injectable vesicular phospholipid gels (VPGs) in vitro and to examine biocompatibility and influence on histology and biomechanical behavior of G-CSF loaded VPGs in a chronic supraspinatus tear rat model. METHODS: G-CSF loaded VPGs were produced by dual asymmetric centrifugation. In vitro the integrity, stability and release rate were analyzed. In vivo supraspinatus tendons of 60 rats were detached and after 3 weeks a transosseous refixation with G-CSF loaded VPGs augmentation (n = 15; control, placebo, 1 and 10 μg G-CSF/d) was performed. 6 weeks postoperatively the healing site was analyzed histologically (n = 9; H&E by modified MOVIN score/Collagen I/III) and biomechanically (n = 6). RESULTS: In vitro testing revealed stable proteins after centrifugation and a continuous G-CSF release of up to 4 weeks. Placebo VPGs showed histologically no negative side effects on the healing process. Histologically in vivo testing demonstrated significant advantages for G-CSF 1 μg/d but not for G-CSF 10 μg/d in Collagen III content (p = 0.035) and a higher Collagen I/III ratio compared to the other groups. Biomechanically G-CSF 1 μg/d revealed a significant higher load to failure ratio (p = 0.020) compared to control but no significant differences in stiffness. CONCLUSIONS: By use of VPGs a continuous growth factor release could be obtained in vitro. The in vivo results demonstrate an improvement of immunohistology and biomechanical properties with a low dose G-CSF application via VPG. The VPG itself was well tolerated and had no negative influence on the healing behavior. Due to the favorable properties (highly adhesive, injectable, biocompatible) VPGs are a very interesting option for biologic augmentation. The study may serve as basis for further research in growth factor application models. BioMed Central 2015-04-10 /pmc/articles/PMC4417541/ /pubmed/25888096 http://dx.doi.org/10.1186/s12891-015-0542-1 Text en © Buchmann et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Buchmann, Stefan Sandmann, Gunther H Walz, Lars Reichel, Thomas Beitzel, Knut Wexel, Gabriele Tian, Weiwei Battmann, Achim Vogt, Stephan Winter, Gerhard Imhoff, Andreas B Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title | Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title_full | Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title_fullStr | Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title_full_unstemmed | Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title_short | Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
title_sort | growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417541/ https://www.ncbi.nlm.nih.gov/pubmed/25888096 http://dx.doi.org/10.1186/s12891-015-0542-1 |
work_keys_str_mv | AT buchmannstefan growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT sandmannguntherh growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT walzlars growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT reichelthomas growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT beitzelknut growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT wexelgabriele growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT tianweiwei growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT battmannachim growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT vogtstephan growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT wintergerhard growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel AT imhoffandreasb growthfactorreleasebyvesicularphospholipidgelsinvitroresultsandapplicationforrotatorcuffrepairinaratmodel |